跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,979 条关于
“CCM-205”
全部
9,979
临床试验
5,447
药物
2,745
机构
36
资讯
1,751
去年
CCM Biosciences to Present Breakthrough 4th-Generation EGFR Inhibitors for NSCLC at ASCO 2025
去年
Recursion's REC-994 Shows Promising Safety and Efficacy Signals in Phase 2 CCM Trial
6个月前
EndoCyclic Therapeutics Receives FDA IND Clearance for First-in-Class Non-Hormonal Endometriosis Treatment ENDO-205
去年
Recursion's REC-994 Shows Promise in Phase II Trial for Cerebral Cavernous Malformations
2年前
Recursion's AI-Derived Drug REC-994 Shows Promise in Phase 2 Trial for Cerebral Cavernous Malformation
3年前
Quanterix Launches Novel P-Tau 205 and P-Tau 212 Assays to Advance Alzheimer's Research
2个月前
Harmony Biosciences Reports Phase 1 Data for Orexin-2 Agonist BP-205, Reinforcing Best-in-Class Potential
2个月前
Viatris Reports Positive Phase 3 Results for VR-205 in Japanese Adults with IgA Nephropathy, Targets 2026 NDA Submission
去年
AnaCardio Raises SEK 205 Million and Reports Positive Phase 1b Data of AC01
去年
Quanterix Launches First-to-Market p-Tau 205 and p-Tau 212 Assays for Alzheimer's Disease Research
第 1 页,共 176 页
上一页
下一页